Showing results (51-60 of 426) with videos related to
Sort By:
Pageof 43
JAMA|August 3, 1979
Erythromycin for anaerobic pleuropulmonary and soft-tissue infectionsE J Goldstein, R P Lewis, V L Sutter, et al.Journal of Clinical Microbiology|February 3, 2000
Survival of aerobic and anaerobic bacteria in purulent clinical specimens maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul transport systemsD M Citron, Y A Warren, M K Hudspeth, et al.Journal of Clinical Microbiology|December 1, 1995
Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringensC J Alexander, D M Citron, J S Brazier, et al.The Journal of Antimicrobial Chemotherapy|March 1, 1993
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazoleE J Goldstein, D M Citron, C E Cherubin, et al.Antimicrobial Agents and Chemotherapy|November 1, 1990
Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium speciesJ S Brazier, E J Goldstein, D M Citron, et al.Journal of Clinical Microbiology|October 8, 1997
Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humansM K Hudspeth, S Hunt Gerardo, D M Citron, et al.Journal of Clinical Microbiology|February 18, 1998
Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rodsM K Hudspeth, S Hunt Gerardo, D M Citron, et al.Antimicrobial Agents and Chemotherapy|July 1, 1986
Susceptibility of Eikenella corrodens to newer and older quinolonesE J Goldstein, D M Citron, A E Vagvolgyi, et al.Antimicrobial Agents and Chemotherapy|September 19, 2000
Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogensE J Goldstein, D M Citron, C V Merriam, et al.Antimicrobial Agents and Chemotherapy|October 30, 1999
Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobesE J Goldstein, D M Citron, C Vreni Merriam, et al.Pageof 43